We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

U.S. NEUROPATHIC PAIN TREATMENT MARKET ANALYSIS

U.S. Neuropathic Pain Treatment Market, by Drug Type (Pain Relievers (NSAIDS, Opioids (Tramadol, Oxycodone, and Others)), Anti-seizure Medications (Gabapentin, Pregabalin, and Others), Topical Treatments, Antidepressants (Duloxetine, Amitriptyline, Escitalopram, and Others), and Others), by Indication (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Dec 2022
  • Code : CMI5429
  • Pages :155
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

U.S. Neuropathic Pain Treatment MarketSize and Trends

request-sample

U.S. Neuropathic Pain Treatment Market Report Coverage

U.S. neuropathic pain treatment market is estimated to be valued at US$ 2,064.9 Mn in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period (2022-2030).

Figure 1: U.S. Neuropathic Pain Treatment Market Share (%) Analysis, By Drug Type, 2022

Figure 2: U.S. Neuropathic Pain Treatment Market Value (US$ Mn) Analysis and Forecast and Y-o-Y Growth (%), 2017-2030

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.